Herein, we demonstrate opposing EZH2 activities even in established PDAC and identify the mutation of the master tumor suppressor gene TP53 as the context-defining molecular event determining EZH2-controlled gene regulation and tumor progression in PDAC maintenance. Here, EZH2 is linked to neoplasm.